In the wake of President-elect Donald Trump’s decision to appoint ex-Democratic Rep. Tulsi Gabbard as his Director of ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...

Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's ...

Now an Australian firm says it can help, with a refinery in Germany set to extract the sought-after mineral from briny ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...